The weekly litigation news digest is live. Subscribe now

IP Verse

An Inhalable Medicament - EP2897588

The patent EP2897588 was granted to Teva Pharmaceuticals on Jul 17, 2019. The application was filed on Nov 21, 2014 under application number EP14809248A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2897588

TEVA PHARMACEUTICALS
Application Number
EP14809248A
Filing Date
Nov 21, 2014
Status
Opposition Rejected
Mar 11, 2022
Publication Date
Jul 17, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
CHIESI FARMACEUTICIFeb 6, 2020BIANCHETTI & MINOJA WITH TREVISAN & CUONZO IPSADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONGB2264238
DESCRIPTIONWO0193933
DESCRIPTIONWO9209323
INTERNATIONAL-SEARCH-REPORTEP2606891
INTERNATIONAL-SEARCH-REPORTUS2003149007
INTERNATIONAL-SEARCH-REPORTUS5676930
OPPOSITIONEP2606891

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents